Related Experiment Video

Updated: Jul 27, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Molecular pathology of tumor metastasis. I. Predictive pathology

J Tímár1, O Csuka, Z Orosz

  • 1Department of Tumor Progression, National Institute of Oncology, Ráth Gy. U. 7-9., Budapest, H-1122 Hungary. jtimar@oncol.hu

Insights

Understanding cancer metastasis is crucial for improving patient outcomes. Research into the molecular mechanisms of tumor spread and diagnostic pathology can enhance the clinical management of disseminated cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Diagnostic Pathology

Background:

  • Despite advances in primary tumor management, disseminated cancer remains a leading cause of death.
  • Lack of understanding of molecular mechanisms driving tumor metastasis hinders clinical progress.
  • Metastasis research is a key focus in oncology, generating fragmented but vital molecular data.

Purpose of the Study:

  • To review current knowledge on the metastatic genotype and phenotype of major human solid tumors.
  • To highlight the role of tumor cell-extracellular matrix interactions in tumor dissemination.
  • To bridge basic research findings with diagnostic pathology for clinical application.

Main Methods:

  • Literature review of metastasis research in oncology.
  • Analysis of gene expression related to tumor cell-extracellular matrix interactions.
  • Synthesis of data on metastatic potential in lung, colon, breast, prostate cancers, and melanoma.

Main Results:

  • Tumor cell-extracellular matrix interactions are critical determinants of metastatic potential.
  • Gene expression profiles can define the metastatic capabilities of malignant tumors.
  • Fragmented molecular data on metastasis is increasingly available.

Conclusions:

  • Translational diagnostic pathology can leverage basic research for clinical insights.
  • Understanding metastatic mechanisms is essential for improving cancer treatment strategies.
  • Further integration of molecular data into clinical practice is needed for managing metastatic disease.